CD25 and TNF receptor II reflect early primary response to infliximab therapy in patients with ulcerative colitis

BACKGROUND: Although infliximab treatment is an option for patients with ulcerative colitis (UC), not all patients do respond to therapy, and cellular mechanisms leading to therapy response are incompletely known. OBJECTIVE: The objective of this article is to determine early effects of infliximab t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Magnusson, Maria K, Dahlén, Rahil, Strid, Hans, Isaksson, Stefan, Simrén, Magnus, Lasson, Anders, Bajor, Antal, Ung, Kjell-Arne, Öhman, Lena
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2013
Gaiak:
Original Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4040739/
https://ncbi.nlm.nih.gov/pubmed/24917999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640613502962
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak